Related Experiment Video
Updated: Jan 7, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Nicotine delivery from and user reactions to nicotine pouches compared to cigarettes
Dunja Przulj1, Katie Myers Smith2, Hayden McRobbie2,3
1Wolfson Institute of Population Health, Queen Mary University of London, 2 Stayner's Road, London, E1 4AH, UK. d.przulj@qmul.ac.uk.
Rationale:
Limited data exist on the potential of nicotine pouches to help smokers quit.
Objectives:
To examine nicotine delivery from and user reactions to a popular nicotine pouch.
Methods:
Twenty smokers provided data after overnight abstinence, first after smoking a cigarette and then, a week or more later, after using 9 mg nicotine ZYN pouch. Blood samples were collected before and 2, 4, 6, 8, 10 and 30 min (and also 60 min in the pouch condition) after starting product use. Participants also rated their urges to smoke at 5, 10, 15 and 30 minutes, and provided ratings of pouch characteristics at the end of the session.
Results:
Pouches delivered nicotine more slowly than cigarettes (Tmax 30 min vs. 6 min, z =-3.93, p < 0.001), though nicotine levels from pouches reached 13 ng/ml within 10 min. Cmax was higher than from cigarettes (27.9 vs. 19.5 ng/ml, t (19) =-2.17, p = 0.043). Both products had the same effect on reducing urges to smoke over 30 min although cigarettes were more effective at 5 min. With pouches, urges to smoke remained low at 60 min. Pouches were rated as delivering more nicotine and being less pleasant than cigarettes; but as effective and as fast in reducing urges to smoke. Three participants who were light smokers experienced nausea and one vomited.
Conclusions:
The initial appeal of pouches to smokers is likely to be more limited than the appeal of products that resemble smoking more closely, and ZYN pouches with 9 mg of nicotine may be too strong for light smokers. However, in terms of nicotine delivery and effects on urges to smoke, pouches have good potential to provide effective replacement for smoking.
More Related Videos
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Delivery: Enteral Route
Drug Dependence